Cargando…

Statistical Parametric Mapping in Amyloid Positron Emission Tomography

Alzheimer’s disease (AD), the most common cause of dementia, has limited treatment options. Emerging disease modifying therapies are targeted at clearing amyloid-β (Aβ) aggregates and slowing the rate of amyloid deposition. However, amyloid burden is not routinely evaluated quantitatively for purpos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Natasha M., Ford, Jeremy N., Haghdel, Arsalan, Glodzik, Lidia, Li, Yi, D’Angelo, Debra, RoyChoudhury, Arindam, Wang, Xiuyuan, Blennow, Kaj, de Leon, Mony J., Ivanidze, Jana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083453/ https://www.ncbi.nlm.nih.gov/pubmed/35547630 http://dx.doi.org/10.3389/fnagi.2022.849932

Ejemplares similares

Positron Emission Tomography reveals age-associated hypothalamic microglial activation in women
por: Butler, Tracy, et al.
Publicado: (2022)

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
por: Therriault, Joseph, et al.
Publicado: (2022)

Parametric and non-parametric Poisson regression for modelling of the arterial input function in positron emission tomography
por: Matheson, Granville J., et al.
Publicado: (2023)

327 Radiopathomics: Integration of Advanced Neuroimaging and Molecular Pathology Features in Meningiomas
por: Haghdel, Arsalan, et al.
Publicado: (2023)

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease
por: Grau-Rivera, Oriol, et al.
Publicado: (2021)

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2022)

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update
por: Farid, Karim, et al.
Publicado: (2017)

Amyloid deposition in semantic dementia: a positron emission tomography study
por: Brown, Eric E., et al.
Publicado: (2016)

Semiquantitative Approach to Amyloid Positron Emission Tomography Interpretation in Clinical Practice
por: Franceschi, Ana M., et al.
Publicado: (2022)

Supporting underrepresented minority students and advancing educational and health equity: Travelers Summer Research Fellowship (TSRF) program radiology panel
por: Yohannes, Nathaniel, et al.
Publicado: (2023)

Approximate Likelihood Estimation of Divergence Time Range Using a Coalescent-based Model
por: RoyChoudhury, Arindam
Publicado: (2013)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations
por: Witte, Michael M., et al.
Publicado: (2015)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Effect of apolipoprotein E phenotype on the association of plasma amyloid β and amyloid positron emission tomography imaging in Japan
por: Tateno, Amane, et al.
Publicado: (2017)

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
por: Chun, Min Young, et al.
Publicado: (2023)

Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
por: Price, Julie C, et al.
Publicado: (2012)

Lacrimal gland uptake on F-18 florbetapir amyloid positron emission tomography scan
por: Itani, Malak, et al.
Publicado: (2017)

Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment
por: Lee, Young-Sil, et al.
Publicado: (2021)

Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity
por: Sala, Arianna, et al.
Publicado: (2020)

Regional Associations of Cortical Superficial Siderosis and β-Amyloid-Positron-Emission-Tomography Positivity in Patients With Cerebral Amyloid Angiopathy
por: Finze, Anika, et al.
Publicado: (2022)

A dataset on body composition, strength and performance in older adults
por: RoyChoudhury, Arindam, et al.
Publicado: (2020)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
por: Thal, Dietmar Rudolf, et al.
Publicado: (2019)

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
por: Lin, Szu-Ying, et al.
Publicado: (2019)

Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment
por: Hu, Yan, et al.
Publicado: (2022)

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [(11)C]AZD2184
por: Nyberg, Svante, et al.
Publicado: (2009)

Anti-Amyloid-β-Mediated Positron Emission Tomography Imaging in Alzheimer's Disease Mouse Brains
por: McLean, Daniel, et al.
Publicado: (2012)

Modeling clustered activity increase in amyloid-beta positron emission tomographic images with statistical descriptors
por: Shokouhi, Sepideh, et al.
Publicado: (2015)

A survey of knowledge and views concerning genetic and amyloid positron emission tomography status disclosure
por: Ott, Brian R., et al.
Publicado: (2016)

AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2016)

Diagnosing Corticobasal Syndrome Based on the Presence of Visual Hallucinations and Imaging with Amyloid Positron Emission Tomography
por: Nishida, Hiroshi, et al.
Publicado: (2017)

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
por: de Wilde, Arno, et al.
Publicado: (2018)

Comparison of Standardized Uptake Value Ratio Calculations in Amyloid Positron Emission Tomography Brain Imaging
por: Knešaurek, Karin, et al.
Publicado: (2018)

Does informant-based reporting of cognitive symptoms predict amyloid positivity on positron emission tomography?
por: Brunet, Hannah E., et al.
Publicado: (2019)

International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer’s Disease
por: Tian, Mei, et al.
Publicado: (2022)

Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity
por: Costoya-Sánchez, Alejandro, et al.
Publicado: (2023)

Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly
por: Kamer, Angela R., et al.
Publicado: (2021)

Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy
por: Yamashita, Kazuto, et al.
Publicado: (2022)

Positron emission tomography
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_h5r6b7ur0sg2c35cck6i5pu4r6